Clinical Trial Update: A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. [Phase 3]

View source ↗

Summary

Study investigating two doses of the HRV vaccine in healthy infants (Phase 3) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Rotavirus
• Rotavirus Infection

Drugs mentioned

• HRV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED